CORD-19:12fbecd4737a9af7b8fab5267094fdfa754f25fa / 22861-23112 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/12fbecd4737a9af7b8fab5267094fdfa754f25fa","sourcedb":"CORD-19","sourceid":"12fbecd4737a9af7b8fab5267094fdfa754f25fa","text":"Given these advantages, and the likelihood that more and diverse families of SMIPs will be discovered, it seems that the imidizaquinoline TL7/8 agonists represent only the first in a long line of future small-moleculebased vaccine adjuvant candidates.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T125","span":{"begin":0,"end":251},"obj":"Sentence"}],"attributes":[{"subj":"T125","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T125","span":{"begin":0,"end":251},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T125","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#ec939b","default":true},{"id":"CORD-19-Sentences","color":"#93b6ec"}]}]}}